Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
Science Alert · 3 Oct 2026

Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial

A flight of stairs can become a challenge for aching knees. Sleep can be broken by repeated breathing problems. For people living with obesity, the effects of the disease can reach far beyond the number on a bathroom scale. Researchers testing an experimental weekly injection therefore tracked more


⬅ Back home Read full article ➡